Author: Medgadged

Machine Learning for Building Personalized Cancer Nanomedicines: Interview with Dr. Daniel Heller

Researchers at the Sloan Kettering Institute and the Weill Cornell Graduate School of Medical Sciences in New York have developed a machine learning approach to design personalized nanoparticle therapies for cancer. Personalized cancer therapies aim to provide a treatment that is tailored to the genetic makeup of a patient’s tumor. They can s (Read more...)

BewellConnect’s MyPeriTens Multi-Action Pelvic Floor Trainer

BewellConnect recently unveiled their new pelvic floor muscle trainer to help women with related issues, including post-partum complications and incontinence. The MyPeriTens device is both an electrical nerve stimulator and electrical muscle stimulator that is controlled through a smartphone app, allowing women to have precise control over the inte (Read more...)

Kinsa Releases QuickCare Wireless Smartphone Thermometer

Kinsa is releasing a new digital smartphone-connected thermometer, the Kinsa QuickCare. It’s modeled on the original Kinsa thermometer that uploaded its readings to a smartphone via the headphone jack. This was a cheap and easy solution that let the company keep the price of the device very low. But, Apple choosing to get rid of […]

Teva Releases First Breath Activated Asthma Inhaler in U.S.

Traditional corticosteroid inhalers for management of asthma symptoms require patients to squeeze and inhale in a coordinated maneuver. This is surprisingly difficult for many patients who end up receiving sub-optimal treatment. Teva Pharmaceutical, Israel’s big pharma firm, is now releasing in the RediHaler, the first breath-activated cortic (Read more...)

Gene Therapy and Optogenetic Goggles for Retinitis Pigmentosa. Interview with Dr. Bernard Gilly, CEO of GenSight Biologics

GenSight Biologics, a biopharmaceutical company based in France, is developing gene therapies for rare diseases that cause blindness. The company has recently received approval in the UK for its Phase I/II PIONEER trial, which will test a treatment combining gene therapy with a visual stimulation device for people with retinitis pigmentosa, an incu (Read more...)

New and Improved Planmed Verity CBCT Scanner Unveiled

Planmed, based in Helsinki, Finland, is releasing an upgraded new version of its popular Planmed Verity CBCT (Cone Beam Computed Tomography) extremity scanner. The system is intended for ortho, as well as head and neck imaging, and even advanced dental applications. It is CE marked in Europe and is now available wherever the mark applies. [… (Read more...)

Embrace Seizure Detection System Cleared in U.S.

The Embrace seizure monitoring watch from Empatica, a company with offices in Cambridge, MA and Milan, Italy, won clearance from the FDA. The device is worn like a watch, continuously monitoring not only the wrist movements, but also electrodermal activity that signals stress, to detect signs of an oncoming or existing seizures. An artificial intel (Read more...)